Capsaicin attenuates immunosuppression induced by chronic stress in BALB/C mice. 2021

J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico.

Although acute stress generally exerts positive effects on the immune system, chronic stress typically causes immunosuppression via the hypothalamic-pituitary-adrenal (HPA) axis. In this study, the effects of capsaicin (1.28 mg/kg intraperitoneally [i.p.] for 7 days) on immune parameters were evaluated under conditions of chronic stress. Capsaicin treatment significantly increased the immune response as evaluated by the delayed-type hypersensitivity (DTH) reaction to dinitrofluorobenzene (DNFB) and splenocyte proliferation assays- It also is able to rescue the splenocytes of the apoptosis induced by stress. The capsaicin treatment increased the production of Th1 cytokines and decreased the production of Th2 cytokines and TGF-β1 in the plasma and culture supernatants of immunosuppressed mice, which is associated with the modulation of Th2 induced by stress cells. Moreover, the production of corticosterone significantly decreased in capsaicin-treated animals as compared to control groups. The capsaicin treatment further attenuated the immunosuppression induced by the corticosterone treatment (40 mg/kg i.p. for 7 days), albeit less potently, as exhibited in the DTH response. Intriguingly, the capsaicin treatment decreased the induction of IL-10, IL-4, and TGF-β1 through high doses of corticosterone, indicating direct cellular immunomodulation. These results show, that capsaicin is able to modulate chronic stress-induced immunosuppression, mediating corticosterone released inhibition, but also, that capsaicin significantly modulates the pharmacological action of corticosterone in vivo.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D002211 Capsaicin An alkylamide found in CAPSICUM that acts at TRPV CATION CHANNELS. 8-Methyl-N-Vanillyl-6-Nonenamide,Antiphlogistine Rub A-535 Capsaicin,Axsain,Capsaicine,Capsicum Farmaya,Capsidol,Capsin,Capzasin,Gelcen,Katrum,NGX-4010,Zacin,Zostrix,8 Methyl N Vanillyl 6 Nonenamide,NGX 4010,NGX4010
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D004139 Dinitrofluorobenzene Irritants and reagents for labeling terminal amino acid groups. DNFB,Fluorodinitrobenzene,1-Fluoro-2,4-dinitrobenzene,1 Fluoro 2,4 dinitrobenzene
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
March 2018, Journal of medicinal food,
J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
January 2009, Neuro endocrinology letters,
J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
June 1987, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ),
J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
September 2021, Immunobiology,
J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
October 2019, Molecular biology reports,
J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
February 2008, International immunopharmacology,
J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
June 2022, Journal of breast cancer,
J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
March 2001, Toxicology letters,
J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
October 1974, Cancer research,
J M Viveros-Paredes, and A M Puebla-Pérez, and O Gutiérrez-Coronado, and A M Macías-Lamas, and G Hernández-Flores, and P C Ortiz-Lazareno, and A Bravo-Cuéllar, and M M Villaseñor-García
January 2007, Molecular and cellular biochemistry,
Copied contents to your clipboard!